Kansas State University

Kansas State University's Barbara Valent outlined genomics research underway to combat a fungal pathogen with the potential to seriously compromise wheat production.

Researchers demonstrate the potential of CRISPR gene editing to prevent disease among livestock, Discover's D-brief blog reports.

Two new papers identified mutations in Puccinia graminis f. sp. tritici avirulence genes AvrSr35 and AvrSr50 that avoid detection by wheat resistance proteins. 

This Week in PNAS

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.

An international team of researchers has sequenced the wild emmer wheat genome and compared it to the genome sequences of domesticated varieties.

The grants are provided through the NSF's Early Concept Grants for Exploratory Research program in partnership with the National Institute of Food and Agriculture.

The genome of the model organism and agricultural pest uncovered a high level of macrosynteny and decreased levels of microsynteny.

Interviews with some of the leading academics in the field of crop research revealed a preference for NGS and genotyping-by-sequencing, in particular.

The funding will also support a partnership developing agricultural educational and training opportunities for students in genomics and bioinformatics.

NEW YORK (GenomeWeb) – Using a synthetic biology-based approach, researchers from the J. Craig Venter Institute and Kansas State University found that a bat influenza virus uncovered in 2009 poses little-to-no pandemic threat to humans.

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.